[Resistant bacteria in Germany. How great are the dangers?].
Kresken
Michael
M
Antiinfective Intelligence, Gesellschaft für klinisch-mikrobiologische Forschung und Kommunikation mbH, Bonn. michael.kresken@antiinfectives-intelligence.de
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001424:Bacterial Infections / Q000188:drug therapy / Q000382:microbiology / Q000451:nursing*; D002648:Child; D017714:Community-Acquired Infections / Q000188:drug therapy / Q000382:microbiology / Q000451:nursing*; D003428:Cross Infection / Q000188:drug therapy / Q000382:microbiology / Q000451:nursing*; D004351:Drug Resistance / Q000235:genetics*; D018432:Drug Resistance, Multiple / Q000235:genetics; D004363:Drug Utilization / Q000706:statistics & numerical data; D005060:Europe; D015964:Gene Expression Regulation, Bacterial / Q000235:genetics; D019450:Genes, MDR / Q000235:genetics*; D005858:Germany; D006801:Humans; D008826:Microbial Sensitivity Tests; D009154:Mutation / Q000235:genetics; D011815:R Factors / Q000235:genetics*
D000900:Anti-Bacterial Agents